[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334600-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334600-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lysine-methyltransferase-5c-increases-the-proliferation-and-metastatic-abilities-of-clear-cell-renal-cell-carcinoma-via-aerobic-glycolysis","Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis","","Clear cell renal cell carcinoma (ccRCC) is the most common and lethal renal cancer subtype, characterized by high risks of metastasis and recurrence. Lysine methyltransferase 5C (KMT5C; SUV420H2), an epigenetic regulator responsible for H4K20 trimethylation, influences key oncogenic processes. The study evaluates KMT5C expression and function in ccRCC, showing markedly higher KMT5C levels in tumor tissues and correlation with poorer overall survival. KMT5C knockdown in ccRCC cell lines reduces aerobic glycolysis through regulation of glycolytic genes, thereby affecting proliferation, EMT, and EMT transcriptional factors.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lysine-methyltransferase-5c-increases-the-proliferation-and-metastatic-abilities-of-clear-cell-renal-cell-carcinoma-via-aerobic-glycolysis/334600/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lysine-methyltransferase-5c-increases-the-proliferation-and-metastatic-abilities-of-clear-cell-renal-cell-carcinoma-via-aerobic-glycolysis/334600.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is KMT5C, and why is it relevant to ccRCC?","Question",{"text":63,"@type":64},"KMT5C (SUV420H2) is an epigenetic modifier that trimethylates H4K20. It regulates cellular processes important for cancer development, and its specific role in ccRCC has been unclear prior to this study.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does KMT5C expression relate to clinical outcomes in ccRCC?",{"text":68,"@type":64},"KMT5C expression is significantly higher in ccRCC tissues than in normal tissues, and it is closely associated with patients’ overall survival.",{"name":70,"@type":61,"acceptedAnswer":71},"How does KMT5C influence ccRCC cell behavior?",{"text":72,"@type":64},"By establishing ccRCC cell lines with KMT5C knockdown, the study links KMT5C to maintenance of aerobic glycolysis via regulation of glycolytic genes. KMT5C also promotes proliferation and EMT by controlling key EMT transcriptional factors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334600,1790154231,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","INTERNATIONAL JOURNAL OF ONCOLOGY 64: 45, 2024  \nLysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis  \nBOHAN ZENG 1‑3* , RUNLAN WAN4* , KUN CHANG 1,2* , JING LI5 , XUANZHI ZHANG 1,2 , GUOHAI SHI 1,2 , DINGWEI YE 1,2 and FUJIANG XU4  \n1Department of Urology, Fudan University Shanghai Cancer Center; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032; 3Department of Urology, Changzheng Hospital, Second Military Medical University (Naval Medical University), Shanghai 200003; 4Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000; 5Department of Respiratory and Critical Care Medicine, Chongqing University Jiangjin Hospital, Chongqing 402260, P.R. China  \nReceived June 25, 2023; Accepted February 8, 2024  \nDOI: 10.3892/ijo.2024.5633  \nAbstract. Among all types of renal cancer, clear cell renal cell carcinoma (ccRCC) is the most common and lethal subtype and is associated with a high risk of metastasis and recurrence. Histone modifications regulate several biological processes that are fundamental to the development of cancer. Lysine methyltransferase 5C (KMT5C; also known as SUV420H2) is an epigenetic modifier responsible for the trimethylation of H4K20, which drives critical cellular events, including genome integrity, cell growth and epithelial‑mesenchymal transition (EMT), in various types of cancer. However, the role ofKMT5C in ccRCC remains unclear. As such, the expression and function of KMT5C in ccRCC were investigated in the present study. KMT5C expression was significantly increased in ccRCC tissues compared with normal tissues (P\u003C0.0001), and it was closely associated with the overall survival rate of patients with ccRCC. By establishing ccRCC cell lines with KMT5C expression knockdown, the role of KMT5Cin the maintenance of aerobic glycolysis in ccRCC cells via the regulation of several vital glycolytic genes was identified. Additionally, KMT5C promoted the proliferation and EMT  \nCorrespondence to: Professor Dingwei Ye, Department of Urology, Fudan University Shanghai Cancer Center, 270 Dong'An Road, Shanghai 200032, P.R. China  \nE‑mail: [dwyelie@163.com](dwyelie@163.com)  \nDr Fujiang Xu, Department of Oncology, The Affiliated Hospital of Southwest Medical University, 25 Taiping Street, Luzhou, Sichuan 646000, P.R. China  \nE‑mail: [fujiangxu@126.com](fujiangxu@126.com)  \n*Contributed equally  \nKey words: clear cell renal cell carcinoma, lysine methyltransferase 5C, aerobic glycolysis, proliferation, metastasis  \nof ccRCC cells by controlling crucial EMT transcriptional factors. Together, these data suggested that KMT5C may act asan oncoprotein, guide molecular diagnosis, and shed light on novel drug development and therapeutic strategies for patients with ccRCC.  \nIntroduction  \nKidney cancer affects >430,000 individuals worldwide, accounting for ~2.2% of all cancer cases (1) . The incidence of kidney cancer continues to increase in both men and women (2), and predictions have indicated that the incidence and mortality of kidney cancer will be >79,000 and almost 13,920 individuals, respectively, in the United States in 2022 (3) . The majority of kidney cancer cases are renal cell carcinoma (RCC), accounting for 90% of all renal malignan‑ cies (4), and the most prevalent (75‑80%) histological RCC subtype is clear cell RCC (ccRCC) (5) . Although ccRCC can be successfully treated with surgical or ablative strategies if diagnosed early, up to a third of patients will present with or develop metastases (6), which is often lethal. Therefore, novel effective biomarkers and treatment strategies should be explored further.  \nIn eukaryotic cells, the functional unit of chromatin is the nucleosome, which is composed of an octamer of four histones (typically H3, H4, H2A and H2B), around which 147 base pairs of DNA are wrapped (7). The core of the nucleosome is form","cbCaioaA8TAsTVkU","https://ap.wps.com/l/cbCaioaA8TAsTVkU","pdf",10337934,13,"English","# Abstract\n# Introduction","[{\"question\":\"What is KMT5C, and why is it relevant to ccRCC?\",\"answer\":\"KMT5C (SUV420H2) is an epigenetic modifier that trimethylates H4K20. It regulates cellular processes important for cancer development, and its specific role in ccRCC has been unclear prior to this study.\"},{\"question\":\"How does KMT5C expression relate to clinical outcomes in ccRCC?\",\"answer\":\"KMT5C expression is significantly higher in ccRCC tissues than in normal tissues, and it is closely associated with patients’ overall survival.\"},{\"question\":\"How does KMT5C influence ccRCC cell behavior?\",\"answer\":\"By establishing ccRCC cell lines with KMT5C knockdown, the study links KMT5C to maintenance of aerobic glycolysis via regulation of glycolytic genes. KMT5C also promotes proliferation and EMT by controlling key EMT transcriptional factors.\"}]","Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis | PDF",1790007432,33]